Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Amarin licenses LAX-202 rights for MS fatigue to Multicell Technologies

Jan. 5, 2006

Closing of Pain Therapeutics and King's strategic alliance

Jan. 5, 2006

Nonapprovable letter for Cesamet labeling changes

Jan. 4, 2006

sNDA submission for Seroquel in bipolar depression

Jan. 4, 2006

Zydus Cadila files IND for antiinflammatory compound ZYI-1

Jan. 4, 2006

Adolor files IND to begin phase I with ADL-5859

Jan. 3, 2006

Novel agents with potential for the treatment of anxiety, depression, etc.

Jan. 2, 2006

Novel agents for treating neurodegenerative disorders disclosed in recent Migenix patent

Jan. 2, 2006

Recent AstraZeneca patents report novel cannabinoid CB1 receptor modulators

Dec. 30, 2005

Targacept and AstraZeneca sign license and research collaboration agreement

Dec. 30, 2005

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...